There was a time when RS21 looked like a promising startup. Anyone still buying into that idea is being misled.
Over the past several years, the company has gone through at least five rounds of mass layoffs, primarily due to overhiring or underdelivering on contracts. The entire C-suite has turned over. The director level has turned over multiple times, often all at once.
The company’s focus has been on short-term decision-making aimed at finding a buyer and generating a return for the owners and investors. That is the end goal. Everything else, from stated values to lofty marketing language, serves as a cover. This short-term mindset has created nearly every major issue RS21 has faced. There is little interest in building lasting value or improving capabilities. Instead, the emphasis is on marketing and vaporware. (Ask about Mother, the 'AI Engine' on the website that never existed, and how potential buyers quickly saw through it.)
They have acqui-hired companies without any real plan for integration, damaging those relationships. Project management has never been figured out, and multiple directors of delivery and operations have come and gone. Executive roles are often handed out just to keep people from leaving, resulting in underqualified leaders in critical positions. Sales teams rarely understand the services or products they are pitching, so turnover is high. Most don’t last more than six months. The company cannot commit to a clear focus, jumping between healthcare, defense, federal, state, and even space. They try to do everything and end up doing none of it well.
Much of RS21’s survival has come from COVID-era loans that did not need to be repaid and personal connections to lab contracts that ultimately went nowhere.
The individual contributors are talented, dedicated, and mission-driven. Unfortunately, they have always been at the mercy of short-sighted leadership. And through it all, only one person has remained in a leadership role from the beginning, central to the ongoing dysfunction.